Clinical Trial

Performance Evaluation of Dream OCT: AP Study

Completed
View on ClinicalTrials.gov →
Summary
This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.
Protocol Amendment History 4 changes
critical Trial completed 2026-07-30
critical Primary endpoint(s) modified 2026-07-30
notable Primary completion pushed: 2026-04 -> 2026-05-12 2026-07-30
minor Completion pushed: 2026-04 -> 2026-05-12 2026-07-30
Trial Details
NCT Number NCT07355491
Lead Sponsor Intalight, Inc
Collaborators: Illinois College of Optometry
Conditions Glaucoma Patients, Retina Patients, Eyes With Corneal Abnormality, Normal Healthy Eyes
Enrollment 120 participants
Start Date 2025-12-16
Primary Completion 2026-05-12 (estimated)
Study Completion 2026-05-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-29